Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 12, 2011 - Issue 13
Submit an article Journal homepage
282
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluations

The current role of high-dose imatinib in chronic myeloid leukemia patients, newly diagnosed or resistant to standard dose

Massimo BrecciaSapienza University, Department of Human Biotechnologies and Hematology, Via Benevento 6, 00161 Rome, Italy+39 06 857 951; +39 06 4424 1984; [email protected]
, MD &
Giuliana AlimenaSapienza University, Department of Human Biotechnologies and Hematology, Via Benevento 6, 00161 Rome, Italy+39 06 857 951; +39 06 4424 1984; [email protected]
Pages 2075-2087 | Published online: 01 Jul 2011

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (4)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.